Mesoblast Ltd

MSB.AX · Moat type: REGULIERUNG

MoatScore

1/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

GESCHÄFTSMODELL Mesoblast Ltd is an Australian biotechnology company specializing in mesenchymal progenitor cells and stem cell therapeutics, attempting to generate revenue through FDA approvals as well as licensing and product revenues from cell-based therapies for inflammatory and degenerative diseases.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.